Thomas Blevins, MD
Enriched profileMedical Director of Clinical Research · Texas Diabetes & Endocrinology
Thomas Blevins is Medical Director of Clinical Research at Texas Diabetes & Endocrinology. OpenAlex indexes 104 publications with 5,459 citations (h-index 31); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Thomas C. Blevins, MD, is Medical Director of Clinical Research at Texas Diabetes & Endocrinology (Austin, TX). The public record shows 104 publications with 5,459 citations (h-index 31), centered on Diabetes Management and Research, Diabetes Treatment and Management, Hyperglycemia and glycemic control in critically ill and hospitalized patients. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 55 companies.
- Most recent indexed publication: 2025 · Journal of diabetes science and technology
- Top research focus: Diabetes Management and Research
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 55 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 49.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Sponsor: DreaMed Diabetes
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Sponsor: Insulet Corporation
- FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump
Sponsor: Texas Diabetes & Endocrinology, P.A.
Industry payments
Updated 27 Aug 2026
55 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year202526 payments$38,077openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202540 payments$29,574openpaymentsdata.cms.gov ↗
- Tandem Diabetes Care, Inc.Program year202523 payments$20,208openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
48.7%Androgen48.5%Testosterone cypionate98%Testosterone1%Testosterone Cypionate1%Part D + Part B≥36 patientsEstrogen0.1%Estradiol100%Part D<11 patientsCardiovascular
19.7%Statin8.4%Rosuvastatin Calcium49%Atorvastatin Calcium39%Pravastatin Sodium6%Simvastatin4%Livalo1%Lovastatin1%Part D<11 patientsCholesterol absorption inhibitor4.6%Ezetimibe100%Part D≥278 patientsMetabolism & gastrointestinal
17.4%GLP-1 receptor agonist5.6%Mounjaro38%Ozempic34%Trulicity25%Rybelsus1%Victoza 2-Pak1%Victoza 3-Pak1%Part D<11 patientsInsulin Analog4.7%Lantus Solostar14%Humalog Kwikpen U-10013%Tresiba Flextouch U-10011%Toujeo Solostar11%Novolog Flexpen9%Humalog6%Novolog5%Toujeo Max Solostar5%Basaglar Kwikpen U-1004%Tresiba Flextouch U-2004%Fiasp Flextouch4%Insulin Lispro Kwikpen U-1003%Levemir Flexpen3%Insulin Aspart3%Lyumjev Kwikpen U-1002%Insulin Aspart Flexpen2%Fiasp1%Lantus1%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 27 Aug 2026
9 congress contributions (2019–2025) across ADA, ENDO per OpenAlex. The most recent:
- 155-OR: Reduced Perceived Diabetes Distress with the Omnipod 5 Automated Insulin Delivery (AID) System in Adults with Type 2 Diabetes (T2D)—Analysis of the SECURE-T2D Study
ADA Scientific Sessions
ADA2025Co-authorOral - 1904-LB: Glycemic Improvement with Use of the Omnipod 5 Automated Insulin Delivery System in Adults with Type 2 Diabetes—Results of the SECURE-T2D Pivotal Trial
ADA Scientific Sessions
ADA2024Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Replacing or Supplementing Automated Insulin Delivery With Inhaled Insulin: A 90-Day Randomized Controlled Trial.
Journal of diabetes science and technology
Article2025 - Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.
Diabetes, obesity & metabolism
Review2024 - A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
Journal of diabetes science and technology
Article2023 - What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
Diabetes, obesity & metabolism
Review2022
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/thomas-blevins-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Thomas-Blevins
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/babsondx_we-are-excited-to-welcome-thomas-blevins-activity-7199045103728885760-pgI8
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/ccsmed_8-dr-thomas-blevins-founder-at-texas-activity-7272315313533210628-uk0H
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
juiceboxpodcast.com/episodes/jbp1212
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →juiceboxpodcast.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗
- Undergraduate education
University of Texas at Austin
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →texasdiabetes.com ↗ - Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗ - Board Certified
Endocrinology and Metabolism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗ - Board Certified
Lipidology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →texasdiabetes.com ↗ - Certified Clinical Densitometrist (CCD)
International Society of Clinical Densitometry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →texasdiabetes.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗
- Member
American Diabetes Association; Texas Medical Association; Travis County Medical Society; International Society of Clinical Densitometry
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasdiabetes.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kxan.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.